On June 15, 2023, FCM MM Holdings, LLC announced that at its annual general meeting (AGM), Mind Medicine (MindMed) Inc. failed to satisfy the basic legal requirement for shareholders to take action at the meeting â the presence of 1/3 of its shares at the AGM. FCM MM Holdings stated that it contends this extraordinarily low level of shareholder participation reflects deep shareholder dissatisfaction and the Companyâs persistent refusal to meaningfully engage with shareholders. FCM MM Holdings also urged shareholders to vote on FCM MM Holdingsâ proxy to support its plan to restore value for all shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.22 USD | -4.97% | -9.87% | +124.59% |
05-13 | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
05-08 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+124.59% | 622M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- FCM MM Holdings Provides Information to Shareholders of Mind Medicine